February 9, 2017
New data on PCSK9 inhibitors is in – and it may bolster patients’ demands for the breakthrough cholesterol drugs in the face of health plan coverage barriers.
February 2, 2017
The American Medical Association and 16 patient, physician, hospital and pharmacy groups have issued a resounding message to health plans: it’s time to reform prior authorizations. In a new principles document, the group calls for data-driven policies that don’t disrupt patient care or unduly burden physicians and their staff.
January 19, 2017
UnitedHealth Group announced higher than expected earnings this week, celebrating an 18 percent year-over-year increase to $185 billion in 2106 revenue. But not everyone’s cheering.
December 16, 2016
Hepatitis C patients keep waiting…and waiting…and waiting.
December 2, 2016
On the heels of recent research confirming breakthrough drugs’ impact on patients with high cholesterol, the Partnership to Advance Cardiovascular Health has released a quick-draw video exploring obstacles for patient access.
November 22, 2016
For patients with extremely high cholesterol, the promise of new PCSK9 inhibitors just keeps growing.
November 18, 2016
Chronic obstructive pulmonary disease, or COPD, often exists undiagnosed and goes undertreated.
November 6, 2016
Heart health has long been on the minds of Americans. About 85.6 million people in this country are living with…
September 23, 2016
Medicine is at a crossroads; cardiology in particular. I saw this fact magnified at the American Society for Preventive Cardiology’s recent town hall on access barriers to PCSK9 inhibitors.
August 30, 2016
A new analysis calls for drastic price reductions for PCSK9 inhibitors, breakthrough lipid-lowering medications. Data published in the Journal of the American Medical Association suggest that the treatments would need to be reduced to two-thirds their current price to meet analysts’ cost-effectiveness thresholds.
